Poster ID Track   Title and Primary Presenter  
  A100 Advances in ADMET & Toxicology   A High-Throughput In Vitro ADME Assay Panel: Incorporation of SPE/MS/MS Into Standard Laboratory Workflow
Vaughn P. Millier -
 
  A110 Advances in ADMET & Toxicology   A New Platform for Evaluation of Cytochrome P450 Induction
Jeff Johnson, PhD -
 
  A101 Advances in ADMET & Toxicology   A Rapid, Label-Free, In Situ Assay Method for Cell Proliferation and Drug Toxicity in Human Cells
Kristi Hohenstein-Elliot -
 
  A107 Advances in ADMET & Toxicology   Automated High Throughput Quantification of Calcium Transients in Primary and Stem Cell-Derived Cardiac Myocytes: Applications for Regenerative Medicine and Cardiotoxicity Screening
Patrick McDonough -
 
  A109 Advances in ADMET & Toxicology   Automated Triplexed Hepatocyte-Based CYP1A, CYP3A And Viability Assays In 96 And 384-well Microplates
Brad Larson -
 
  A102 Advances in ADMET & Toxicology   Automation of B-CLEAR® Technology for Evaluation of Drug Transport.
Cassandra H. Perry -
 
  A103 Advances in ADMET & Toxicology   Electrophysiological Cardiac Safety Assessment in Drug Discovery and Development
Dirk Winkler -
 
  A108 Advances in ADMET & Toxicology   Generation of New, Highly Restrictive. Conditionally Immortalized Human Brain Microvascular Endothelial Cell Line
Anatoliy Koval -
 
  A105 Advances in ADMET & Toxicology   High-Content Imaging Analysis of Cell Loss, Cellular Redox State, ROS Production and Mitochondrial Membrane Potential Predict Drug Hepatotoxicity
Richik Ghosh -
 
  A106 Advances in ADMET & Toxicology   Higher Throughput Human Hepatocyte Assays for Adverse Drug Properties
Albert Li -
 
  B200 Advances in Assay Technology   A High-Throughput 1,536-Well Luminescence Assay for Glutathione S-Transferase Activity
Adam Yasgar -
 
  B266 Advances in Assay Technology   A Homogeneous Assay to Replace EMSA in the Monitoring of DNA-Protein Interaction.
Dahan Sophie -
 
  B202 Advances in Assay Technology   A Homogeneous Chemiluminescent IL-8 Assay Based on SPARCL Technology
Barry Schoenfelner -
 
  B203 Advances in Assay Technology   A Homogeneous Chemiluminescent TNF-alpha Assay Based on SPARCL Technology
Barry Schoenfelner -
 
  B204 Advances in Assay Technology   A Homogeneous, Solution Phase Competitive cAMP Assay Based on SPARCL Chemiluminescent Technology
Renuka de Silva -
 
  B205 Advances in Assay Technology   A Method to Develop High Affinity Protein Ligands - Backwards
Chris Diehnelt -
 
  B206 Advances in Assay Technology   A Multiplexed Screening Method Correlating Compound Toxicity Dose Effects with Cell Type, Cell Health and Culture Conditions Utilizing the HyperCyt® System for High-throughput Flow Cytometry.
Christopher Black -
 
  B207 Advances in Assay Technology   A Novel Assay to Measure Renin Activity in Mouse Plasma
Elizabeth Cauchon -
 
  B208 Advances in Assay Technology   A Novel Feeder-Free Pluripotent Stem Cell Culture Substrate that Supports Mouse Embryonic and Human Induced Pluripotent Stem Cell Growth and Proliferation
Thomas Zarembinski -
 
  B201 Advances in Assay Technology   A Novel Homogeneous Chemiluminescent Sandwich GM-CSF Assay Based on SPARCL Technology
Barry Schoenfelner -
 
  B211 Advances in Assay Technology   A Real-time Fluorescence Assay development for Specialized Human DNA Polymerases
Dorjbal Dorjsuren -
 
  B278 Advances in Assay Technology   A Real-Time Informatics Platform to Enable Automated Coupling of High-Throughput Screening and High Content Imaging of Large Chemical Libraries
Sunita Shukla -
 
  B2101 Advances in Assay Technology   Acoustic Droplet Ejection Enables Efficient and Reproducible Transfer of siRNA for Library Based Screening
Carl Jarman -
 
  B212 Advances in Assay Technology   Adaptation of Angiogenesis and Cancer Cell Invasion Assays in to Well Plate Microfluidic Flow Devices Enables Using Real-Time Microscopy
Carolyn Conant -
 
  B213 Advances in Assay Technology   Adhesive Micropatterns for High Content Screening: A Case Study
Constantin Nelep -
 
  B214 Advances in Assay Technology   Aequorin Assays In Primary Endothelial Cells Using the Amaxa® Nucleofector® Technology
Ann Siehoff -
 
  B215 Advances in Assay Technology   An Automated, Quantitative High-Content Cell-Based Imaging Assay for Chemotaxis
Richik Ghosh -
 
  B216 Advances in Assay Technology   Analysis Of TrkB Activity In Complex With TDA 2.0™: A HTS-Compatible Assay with Altered Relevant Substrate Preference
Scott Gridley -
 
  B223 Advances in Assay Technology   Analyzing Phospho-Akt from Cell Culture & Tumor Lysates Using the BioScale’s Acoustic Membrane and Microparticle (AMMP™) technology on the ViBE™ BioAnalyer
Zhong-Hua Yan -
 
  B279 Advances in Assay Technology   Assessing Mechanism of Action Of Cytotoxicity Using High Content Imaging Methods
Chandrasekaran Vasudevan -
 
  B257 Advances in Assay Technology   Assessing Protein Structural Changes by Dual Polarization Interferometry
Kristin Coan -
 
  B219 Advances in Assay Technology   Automated Analysis of Embryoid Bodies Enables Correlation of Size and Differentiation Potential
Kristi Hohenstein-Elliot -
 
  B220 Advances in Assay Technology   Automated and Real-Time Monitoring Of Cell Migration, Cell Invasion and Cell Scattering Using The xCELLigence System from Roche Applied Science
Jing Zhang -
 
  B221 Advances in Assay Technology   Bacterial Motility Assay in 384-Well Format for HTS
Lucile White -
 
  B222 Advances in Assay Technology   Biomarker Analysis of GADD34 Induction by Proteasome Inhibition from Cell Culture & Xenograft Tumor Lysates Using the BioScale’s Acoustic Membrane and Microparticle (AMMP™) technology on the ViBE™ Bioanalyer
Michael Bembenek -
 
  B217 Advances in Assay Technology   Catalytic Activity of Receptor Tyrosine Kinase Cytoplasmic Domains Strongly Dependant on Template-Directed Assembly
Scott Gridley -
 
  B224 Advances in Assay Technology   Cell-Based Assays for G-Protein Independent Signaling Using Arrestin Binding and Endocytosis
DiscoveRx Corporation -
 
  B225 Advances in Assay Technology   Characterization of Novel Beta-Subunit-Selective Luminogenic Substrates of the Proteasome
Khristofer Garcia -
 
  B2103 Advances in Assay Technology   Chemotaxis in High-Throughput: Label-Free And Transwell-Free BIND® Assays
Steve Shamah -
 
  B226 Advances in Assay Technology   Comparison Between Alpha-Tubulin And Histone H4 Peptide Substrates For SIRT2 Enzyme Inhibitor Screening Assays
Lavleen Gupta -
 
  B227 Advances in Assay Technology   Comparison of Microplate Surface Treatments for Use In Calcium Channel Assays
Mark Rothenberg -
 
  B280 Advances in Assay Technology   Creating Cell-Based Assays for Screening GPCRs, Ion Channels and Other Targets in Cell Lines and Primary Cells Using the MaxCyte® STX™ Scalable Transient Transfection System
James Brady, PhD -
 
  B228 Advances in Assay Technology   Cytotoxicity Profiling of the Anticancer Agent Thiostrepton
Paul held -
 
  B229 Advances in Assay Technology   Development of a Dual-Purpose Assay for High-Throughput Identification of Both Substrates and Inhibitors of TrxR1
Thomas Dexheimer -
 
  B230 Advances in Assay Technology   Development of a Live-Cell Based Reactive Oxygen Species (ROS) Assay for use in High-Content Screening of Drug Candidates Using the BioTek Synergy Mx Microplate Reader.
Xavier Amouretti -
 
  B231 Advances in Assay Technology   Development of Label-Free Cell-Based Assays Using Primary Neuronal Cells
Alice Gao -
 
  B234 Advances in Assay Technology   Evaluation of a Generic ADP Detection Assay: ADP-Glo™
Leng Lor -
 
  B235 Advances in Assay Technology   Evaluation of Lewis Acid Kinase Assay Reagent and Comparison with IMAP
Hong Qian -
 
  B236 Advances in Assay Technology   Expanding the Toolbox Of Gamma-Irradiated Frozen Cells Validated for GPCR-Mediated Kinase Signaling
Michael Crouch -
 
  B249 Advances in Assay Technology   False Positives from a Homogeneous Time Resolved Fluorescence Screen Due to a Compound and Serum Interaction
David Cronk -
 
  B239 Advances in Assay Technology   FLEXYTE Protease and Protein Kinase Assays: Realising the Benefits of Fluorescence Lifetime for Drug Discovery Applications
Graham Cotton -
 
  B2100 Advances in Assay Technology   Functional Validation of Novel Disease Targets by Lentiviral ShRNA or CDNA Delivery
Pascale Bouillé -
 
  B281 Advances in Assay Technology   Generating 1536-Well Assay Ready Plates On Demand for HTS Dose Response Curves Using Acoustic Technology
Manori Turmel -
 
  B240 Advances in Assay Technology   Top Ten Winning Poster
Genetic Chemistry Platform Applied to Identification of Anti-Viral Compounds
Markus Schwab -
 
  B242 Advances in Assay Technology   High Throughput Cardiotox Screening Using Human IPS Cell Derived Cardiomyocyte and Novel 96-Well Plate
Yasuyuki Asai -
 
  B243 Advances in Assay Technology   High Throughput Detection of Antibiotic Resistance Markers on Microarray Using Stringency Wash Optimized Workstation.
Olga Golovleva -
 
  B244 Advances in Assay Technology   High Throughput Imaging Assays to Assess Cell Migration
Jayne Hesley -
 
  B282 Advances in Assay Technology   High-Content Screening - Blessing or Curse?
Susanne Heynen-Genel -
 
  B245 Advances in Assay Technology   Highly Efficient Liposome and Lipoparticle Capture for SPR Interaction Studies Using the MemLAYER Capture Kit
Wong Sheryl -
 
  B246 Advances in Assay Technology   Highly Sensitive Fluorimetric Assay for Thiol Quantification
Ming Zhu -
 
  B2102 Advances in Assay Technology   High-Throughput Label-free, BIND® Assays for Monitoring Stem Cell Differentiation
Steve Shamah -
 
  B247 Advances in Assay Technology   High-Throughput Multiplexed Assay For Analysis Of Hematopoietic Stem Cells Differentiation And Hematopoietic Toxicity
Oksana Sirenko -
 
  B2107 Advances in Assay Technology   Homogeneous Cell-Based Signal Transduction Assays
Peter Banks -
 
  B248 Advances in Assay Technology   HTS Compatible Cellular and Biochemical Assays for the Discovery of Retinoid-Related Orphan Receptor Ligands
Mark Federici -
 
  B237 Advances in Assay Technology   HTS-Amenable Cell-Based Assays for Endogenous STAT1/3/5 Protein Phosphorylation for Drug Screening of Cytokine Pathways
Michael Crouch -
 
  B283 Advances in Assay Technology   Identification of Protein Phosphatase-5 (PP5) Inhibitors by Fluorescence-Based Biochemical Ultra High Throughput Screening Assay
Claude-Henry Volmar, PhD -
 
  B284 Advances in Assay Technology   Identification of Small Molecule Inhibitors of Platelet Granule Secretion; Development of Novel Label-Free High Throughput Assay
Joseph Negri -
 
  B285 Advances in Assay Technology   Illuminating Insights From a Chemical Profile of Firefly Luciferase Inhibitors
Natasha Thorne -
 
  B286 Advances in Assay Technology   In Search Of New Antifungal Agents: Ultra High Throughput Screening For TPT1 Inhibitors
Anna Knapinska -
 
  B250 Advances in Assay Technology   Incorporation of Nanopipetting Technology into a Drug Discovery Screening Platform
Jennifer Jackson -
 
  B251 Advances in Assay Technology   Ionworks Barracuda Enables 384 Simultaneous Recordings of Ligand and Voltage-Gated Ion Channels
James Costantin -
 
  B252 Advances in Assay Technology   Top Ten Winning Poster
Large Scale Production and Characterization of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes For use In Assessing Cardiotoxicity.
Blake Anson -
 
  B287 Advances in Assay Technology   Localised Surface Plasmon Resonance (LSPR) with Colloidal Gold Nanoparticles: A Novel Approach to High Throughput and Sensitive Label-Free Detection on Standard Laboratory Equipment
Patrick Englebienne -
 
  B253 Advances in Assay Technology   Luminescence Assay Using Rat Lower Intestinal GLP-1 Secreting Primary Cultured Cell Being Transfected Bacmam Aequorin with Hamamatsu FDSS7000
Sunao Hisada -
 
  B254 Advances in Assay Technology   Luminescent Enzymatic Activity Assays For The ATP- And DNTP-Dependent Enzymes.
Val Golovlev -
 
  B288 Advances in Assay Technology   Mastering HCS Data Management in High-Throughput Style: Automated Analysis, Systematic Quality Control and Multiplexed Hit List Generation
Oliver Leven -
 
  B255 Advances in Assay Technology   Mechanistic Signatures of Drug Responses in Cancer
Nathan Moerke -
 
  B289 Advances in Assay Technology   Meganuclease-Driven Targeted Integration In CHO-K1 Cells for the Fast Generation of HTS Compatible Cell-Based Assays
Olivier Nosjean -
 
  B256 Advances in Assay Technology   Microenvironment Array for High-Throughput Cell Culture Condition Screening
Toshiyuki Kanamori -
 
  B218 Advances in Assay Technology   Top Ten Winning Poster
Mimicking Membrane-associated Kinase Activity in an in vitro Enzymatic Assay for HTS: Template-Directed Assembly of Lyn kinase using TDA 2.0™
Scott Gridley -
 
  B258 Advances in Assay Technology   Multiparametric Homogeneous Method for Identification of Ligand Binding To GPCR: Receptor-Ligand Binding, Beta-Arrestin and cAMP Assays
Harri Härmä -
 
  B259 Advances in Assay Technology   New Assays for Characterization of 4E-BP1 and 4E-B2 Signaling
Mark Dronsfield -
 
  B290 Advances in Assay Technology   New Software Technology that Enables Scientists to Design and Build their own Assays
Carl Hull -
 
  B260 Advances in Assay Technology   New SPARCL Chemiluminescent Immunoassay Technology
Wenhua Xie -
 
  B261 Advances in Assay Technology   Next Generation Bacmam Aequorin: Potential Applications
Thomas Gainer -
 
  B262 Advances in Assay Technology   Northwestern University High Throughput Analysis Laboratory: An Open-Resource for High Throughput Biology and Drug/Biomarker Discovery
Chi-Hao Luan -
 
  B263 Advances in Assay Technology   Novel Fluorescence-Based Microplate Assay for Screening Inhibitors of Thioredoxin and Protein Disulfide Isomerase
Andrew Whiteley -
 
  B2108 Advances in Assay Technology   Optimizing A Luminescent Calcium Biosensor For Screening GPCRS On Multiple Detection Platforms
Blaine Armbruster -
 
  B291 Advances in Assay Technology   Parallel Label-Free Fragment Screening Using A Biacore™ Prototype System
Olof Karlsson -
 
  B292 Advances in Assay Technology   Perfusion Culture Microchamber Array Chip for High Throughput Drug Dose Response Assay
Shinji Sugiura -
 
  B2104 Advances in Assay Technology   Profiling Compound Toxicity Using Label-Free BIND® Technology from SRU Biosystems
Eric Sandberg -
 
  B265 Advances in Assay Technology   Rapid Cell-based Assays using Multiplexed Mitochondrial and Cell Health Markers
Julie L. Clor -
 
  B209 Advances in Assay Technology   Rapid Fragment Screening with a Robotically Automated ForteBio Octet RED384
Frank Podlaski -
 
  B293 Advances in Assay Technology   Rapid, Cost Effective and Easy Screening of Membrane Proteins
Kenneth Olesen -
 
  B294 Advances in Assay Technology   Real-Time Label-free Assays for Endogenous GPCR Function.
Yama Abassi -
 
  B295 Advances in Assay Technology   Screening Genetic Diversity Using Automated Highly Parallel Cell Culture
Robin Felder -
 
  B267 Advances in Assay Technology   Secreted App and Amyloid Beta Quantification In SH-SY5Y Cell Media Using High Sensitivity Alphalisa Kits
Dahan Sophie -
 
  B268 Advances in Assay Technology   Selective Cell Detachment Using Photo-Responsive Culture Substrates
Kimio Sumaru -
 
  B269 Advances in Assay Technology   Selective Cell Killing Using Photo-Acid-Generating Polymers
Kyoko Kikuchi -
 
  B296 Advances in Assay Technology   Signal-Locking Fourier Transform Spr: A New Low-Noise Detection Technique for Biomolecular Interactions
Williams Layne -
 
  B271 Advances in Assay Technology   Small Molecule and Fragment Screening using Bio-Layer Interferometry
Sriram Kumaraswamy -
 
  B297 Advances in Assay Technology   Strategies for Improving RNAi Screening Success: Using a Ubiquitin-EGFP Assay to Identify Druggable Genes Required for Proteasome Function
Anja Smith -
 
  B272 Advances in Assay Technology   SWAP: A High Throughput Automated Microfluidic Alternative to Western Blotting
Laurel Provencher, PhD -
 
  B273 Advances in Assay Technology   Transcreener® Assay ADP2 Assays: Streamlining Inhibitor Profiling for Kinases with Diverse ATP Requirements
Meera Kumar -
 
  B274 Advances in Assay Technology   TR-FRET HTS Statistical Method for Outlier Identification
Patrick Bingham -
 
  B275 Advances in Assay Technology   Two Secreted Orthogonal Bioluminescent Reporters for Ultrasensitive High Throughput Assays
George Tzertzinis -
 
  B298 Advances in Assay Technology   Ultra-High-Throughput Screening of Poorly Characterized Enzymes via Fluorescence Polarization- Activity-Based Protein Profiling (fluopol-ABPP)
Virneliz Fernandez-Vega -
 
  B276 Advances in Assay Technology   Up- And Down-Regulation Caused By RXR Agonist And HMG-CoA Reductase Inhibitor are Detectable With HTRF® Apo-A1 And Apo-B Assays.
Koji Adachi -
 
  B277 Advances in Assay Technology   Using Polypropylene Microplates in Luminescence Based Biochemical Assays
Rainer Heller -
 
  C300 Advances in Automation, Liquid Handling and Detection Platforms   1536-Well Miniaturized Pcr Enabled By Acoustic Droplet Ejection
Siobhan Pickett -
 
  C301 Advances in Automation, Liquid Handling and Detection Platforms   A Mix-and-Read Cell-Based Assay for Antibody Screening Against Epithelial Growth Factor Receptor
Donald Bennett -
 
  C302 Advances in Automation, Liquid Handling and Detection Platforms   A Spotter Technology for Rapid and High Resolution Deposition of HPLC Effluent Aiming at Further Off-Line Bioaffinity Analysis
Jeroen Kool -
 
  C303 Advances in Automation, Liquid Handling and Detection Platforms   An Automated, High Throughput Screening System to Perform Large Scale Screening of Cellular Assays
Patrick Humphrey -
 
  C304 Advances in Automation, Liquid Handling and Detection Platforms   Automated Fabrication Of Scaffolds For 3D Cell-Based HTS Assays
William Kisaalita -
 
  C305 Advances in Automation, Liquid Handling and Detection Platforms   Automated High Throughput Potency Determinations on Thousands of Compounds as Part of Primary HTS Campaigns
James LaRocque -
 
  C306 Advances in Automation, Liquid Handling and Detection Platforms   Automated High-Throughput Single-Cell Cytotoxicity Analysis By Flow Cytometry - Integrated Biomek® -HyperCyt®-CyAn ADP Workstation"
Michael Kowalski -
 
  C307 Advances in Automation, Liquid Handling and Detection Platforms   Automated Nanolitre Hit-Picking Using A Mosquito® X1 Low Volume Pipettor
Joby Jenkins -
 
  C308 Advances in Automation, Liquid Handling and Detection Platforms   Automating Sample Preparation for Single-Cell Protein Phosphorylation Analysis by Flow Cytometry
Li Liu -
 
  C309 Advances in Automation, Liquid Handling and Detection Platforms   Demonstrating the Positive Impact on Assay Quality and Throughput 384 and 1536 Well Format By Using a Temperature Controlled, Automated High Throughput Screening System
Amalia Ignberg -
 
  C310 Advances in Automation, Liquid Handling and Detection Platforms   Development and Optimization of a Miniaturized Ip-One HTRF Cell-Based Assay For Human GPCR Agonist Screening Using Adherent Frozen HEK293 Cells in a Non-Washed Format
VIncent Yu -
 
  C311 Advances in Automation, Liquid Handling and Detection Platforms   Development of a Miniaturized Fluorescence Detection System for the Hyphenation Of NanoLC To On-Line Biochemical Assays
Ferry Heus -
 
  C319 Advances in Automation, Liquid Handling and Detection Platforms   Evaluating Five Microplate Mixing Techniques  Diffusion, Centrifugation, Shaking, Pipetting and Ultrasonic Mixing
Jean Shieh -
 
  C313 Advances in Automation, Liquid Handling and Detection Platforms   Evaluation of the Formulatrix Tempest at Emd Serono: A Flexible Low Volume Liquid Handler with Two Axis Gradient Dispensing Capability.
Vikram Shankar -
 
  C337 Advances in Automation, Liquid Handling and Detection Platforms   Exploring the Benefits of Echo Dispensing into Cell Plates
Stacey Barto -
 
  C314 Advances in Automation, Liquid Handling and Detection Platforms   Gradient, Contact-Free, Volume Transfers Minimize Compound Loss in Dose-Response Experiments
Joe Olechno -
 
  C315 Advances in Automation, Liquid Handling and Detection Platforms   High Throughput Acoustic Cherry Picking and Dose Response Applications on a Highly Flexible Automation Platform
Jack Dawson -
 
  C317 Advances in Automation, Liquid Handling and Detection Platforms   High-Precision Acoustic Transfer of Buffered Solutions Containing Surfactant and Protein for Miniaturized Biological Assays
Sammy S. Datwani -
 
  C316 Advances in Automation, Liquid Handling and Detection Platforms   HighRes Biosolutions NanoCell: A Novel Robotic Platform for Multiple Use Laboratories
Jack Dawson -
 
  C318 Advances in Automation, Liquid Handling and Detection Platforms   Homogeneous ADP Detection Using Transcreener® Technology on Tecan’s Infinite® F500 and Infinite® M1000 Multimode Microplate Readers
Ingo Montenbruck -
 
  C312 Advances in Automation, Liquid Handling and Detection Platforms   Implementing Digital Video Recording to Increase Laboratory Efficiency
Simon Rose -
 
  C320 Advances in Automation, Liquid Handling and Detection Platforms   Improve the Integrity of Your Fragment Library for Fragment-Based Drug Discovery
Jean Shieh -
 
  C336 Advances in Automation, Liquid Handling and Detection Platforms   Improving Screening Results Using High-Speed Vision Technology
Chris Walsh -
 
  C322 Advances in Automation, Liquid Handling and Detection Platforms   Integration of Acoustic Liquid Transfer Technology into a Cellular Profiling Workflow
Timothy Smith -
 
  C323 Advances in Automation, Liquid Handling and Detection Platforms   Label Free Technology: The Weird and Wonderful World of Cell Signalling
David Cronk -
 
  C324 Advances in Automation, Liquid Handling and Detection Platforms   Label Free Technology: Value Added Information in the Drug Discovery Process
David Cronk -
 
  C325 Advances in Automation, Liquid Handling and Detection Platforms   Label-Free Interaction Analysis in Hit Selection- Insights into Biomolecular Interactions Using Kinetic and Thermodynamic Analysis
Verna Frasca -
 
  C327 Advances in Automation, Liquid Handling and Detection Platforms   New Driver Design Increases Throughput of FLIPR TETRA System Intergrated On BioCel Robot
Avian E. Townley -
 
  C329 Advances in Automation, Liquid Handling and Detection Platforms   Optimization of the Protocol For DNA Purification From Blood for Thermo Scientific Kingfisher Flex
Merja Mehto -
 
  C330 Advances in Automation, Liquid Handling and Detection Platforms   Precise and Accurate Transfer of Kinase Enzymes Using Acoustic Droplet Ejection
howard lee -
 
  C331 Advances in Automation, Liquid Handling and Detection Platforms   Rapid Generation of Assay-Ready Serial Dilution Plates Using Two Stage Low Volume Pipetting
Ben Schenker -
 
  C332 Advances in Automation, Liquid Handling and Detection Platforms   Rapid N-Glycan Analysis Sample Prep on an Automatable Micro Chromatography Platform
Scott Fulton -
 
  C333 Advances in Automation, Liquid Handling and Detection Platforms   The Use of Conformation Activity Relationship in Drug Discovery
Gerry Ronan -
 
  C334 Advances in Automation, Liquid Handling and Detection Platforms   Ultra High Throughput ELISA Screen in 1536-well Format of a Protein-Protein Interaction
Adam Amoss -
 
  C335 Advances in Automation, Liquid Handling and Detection Platforms   Uncovering Liquid Handler Behavior - Do you Really Know How your Robot is Performing for Your Assays?
John Bradshaw -
 
  C321 Advances in Automation, Liquid Handling and Detection Platforms   Utilizing an Automated Tissue Culture Platform to Characterize, Maintain, Expand and Screen Adherent and Suspension Cell Lines
Timothy Smith -
 
  D400 Advances in High Content Screening and Information Technologies   A New Microconduit Array Plate for Neutrophil Chemotaxis That is Compatible with High Throughput Laser Scanning Instrumentation
Tracy Worzella -
 
  D401 Advances in High Content Screening and Information Technologies   A Nine-Parameter Cytotoxicity Assay to Determine the Toxic Effects of Compounds In HepG2 Cells
Yang Tian -
 
  D402 Advances in High Content Screening and Information Technologies   A Novel Genome-wide Screening Application Using Pooled Viral miRNA-adapted shRNA (shRNAmir) Libraries
Kruti Patel -
 
  D415 Advances in High Content Screening and Information Technologies   A Novel Method to Simultaneously Quantify Antibody Production and Cell Health Utilizing the System for Cell-based Screening.
Thomas Duensing -
 
  D416 Advances in High Content Screening and Information Technologies   Autoantigen Biomarker Discovery Through Immunological Profiling with Functional Protein Microarrays
Thien Dinh -
 
  D404 Advances in High Content Screening and Information Technologies   Top Ten Winning Poster
Automation Of Complex Cell Models - Investigating Modulators of Angiogenesis In Vitro
Anesh Sitaram -
 
  D405 Advances in High Content Screening and Information Technologies   BacMam Gene Expression In Neurons For Functional And Imaging Applications
Daniel Beacham -
 
  D418 Advances in High Content Screening and Information Technologies   Bioassay Ontology and Software Tools to Integrate and Analyze Diverse Data Sets
Uma Vempati -
 
  D417 Advances in High Content Screening and Information Technologies   Detection And Quantification of Perilipin Phosphorylation in Adipocytes Via Immunocytofluorescence And High Content Analysis
Patrick McDonough -
 
  D406 Advances in High Content Screening and Information Technologies   Development of a Fluorescence-Based Assay to Screen Drugs Against AlzheimerS Disease
Clarisa Salado -
 
  D407 Advances in High Content Screening and Information Technologies   Direct Fluorescent Labelling Approaches For G-Protein Coupled Receptors Using the Arrayscan® VTI HCS Reader
Alison Carter -
 
  D408 Advances in High Content Screening and Information Technologies   High Throughput TCRP-based Phenotypic Screening for Anticancer Drug Discovery Using the xCELLigence Label-free Cell-Based Assay System
Min Zheng -
 
  D409 Advances in High Content Screening and Information Technologies   High-Throughput Analysis of Nuclear Dynamics through the Combination of a Novel Cell-Permeant Fluorescent Probe and a Laser-Scanning Microplate Cytometer
Paul Wylie -
 
  D410 Advances in High Content Screening and Information Technologies   Top Ten Winning Poster
HyperCyt® PRO: An Advanced Platform for Collecting, Managing and Sharing Data from Multiplate Flow Cytometry Screening
Linda S. Trinkle -
 
  D411 Advances in High Content Screening and Information Technologies   Integrating an Automated In Vitro Combination Screening Platform with Live-Cell and Endpoint Phenotypic Assays that Provide Mechanistic Insight to Support the Testing of Drug Combinations
Sandeep Daya -
 
  D412 Advances in High Content Screening and Information Technologies   Measuring of Migration in Fully Automated Imaging Based Approach
Simone Schicktanz -
 
  D413 Advances in High Content Screening and Information Technologies   Simultaneous Measurement of Cytotoxicity, Proliferation and Cell Cycle Progression using a Simple Two Dye Method
Wayne Bowen -
 
  D414 Advances in High Content Screening and Information Technologies   Use of Muscale CMAcfz Automated Image Analysis Software to Accurately Quantitate Cell Migration
Asaad Said -
 
  E508 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Are Natural Products Delivering? Experiences and Recommendations From 20 Screening Campaigns.
Peter Eckard -
 
  E500 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   BacMam Wave Bioreactor Process Optimization
Mark Tibbetts -
 
  E501 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Biological Properties of a Novel Stereochemically Diverse Compound Collection at the Broad Institute
Joshua Bittker -
 
  E509 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Cell-based Assays Using Biosensors and Reporter Genes in Primary Cells
Nicole Faust -
 
  E502 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Comparison of Mouse ES Cell-Derived Cardiomyocytes and Human iPS-Derived Cardiomyocytes for Electrophysiology: Use of Microelectrode Arrays
Silke Schwengberg -
 
  E510 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   comPOUND D2: a simple approach to increasing sample storage capacity
Ben Schenker -
 
  E511 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Critical Processes and Bottlenecks in the Implementation and Execution of uHTS Chemical Probe Discovery Projects for the NIH Roadmap Molecular Libraries Program
Thomas Chung -
 
  E507 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Gene Subcloning Technologies and Applications in Expression Construct Generation
Quinn Lu -
 
  E505 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   High Quality Gene Assembly from Microarray Synthesized Oligonucleotides.
Alex Borovkov -
 
  E512 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Identification of Allosteric Agonists of CXCR4 Using a Pepducin Library
Yong Ren -
 
  E513 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Meeting the Cellular Needs for High Through-Put Screening
Tom Sweitzer -
 
  E506 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Production of Multimeric Proteins With Two Different Techniques.
Lukas Leder -
 
  E514 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Real-Time Dynamic Monitoring of Cell Identity and Quality for Cell-based Screening.
Yama Abassi -
 
  E503 Critical Reagents: Library Design, Sample Management, Biologicals and Logistics   Susceptibility of Mouse ESC Derived Cardiomyocytes to Mitochondrial Toxicants in Cell Culture Media Using Different Sugars as Energy Source
Silke Schwengberg -
 
  F600 Epigenetics Targets in Drug Discovery   A Homogeneous, Single Addition Bioluminescent Assay for HDAC Class I and II Activities
Andrew Niles -
 
  F601 Epigenetics Targets in Drug Discovery   A Homogeneous, Single Addition Bioluminescent Assay for Sirtuin Activities
Terry Riss -
 
  F607 Epigenetics Targets in Drug Discovery   A Novel Class Of Dual-Inhibitors Of PLTP And CETP for the Treatment of Atherosclerosis
Karim Berrada -
 
  F602 Epigenetics Targets in Drug Discovery   A Novel Non-Rad Homogeneous Assay Using the Alpha Technology to Monitor Full Length Histone Protein Methylation.
Nathalie Rouleau -
 
  F603 Epigenetics Targets in Drug Discovery   Characterization of Hdac Inhibitors Using Microfluidic Mobility-Shift Detection
Abbie Esterman -
 
  F604 Epigenetics Targets in Drug Discovery   Epigenetics Targets - Efficient Hit Finding Approaches
Doris Hafenbradl -
 
  F605 Epigenetics Targets in Drug Discovery   HDAC2 Screening Assay Using the Fluor de Lys®-Green Substrate
Mark Engleka -
 
  F606 Epigenetics Targets in Drug Discovery   Implementation of a Platform Dedicated to Histone Deacetylase Screening and Profiling
Laurent Pépin -
 
  G729 GPCRs in Drug Discovery   A High Throughput Screen Using A Modified Camp Biosensor Assay to Identify Potential Gpcr Positive Allosteric Modulators
Victoria Wong -
 
  G700 GPCRs in Drug Discovery   A PathHunterTM Ultra High Throughput Screen of a Gi-coupled GPCR Identifies Both Neutral and Beta-Arrestin-Biased Ligands
Amita Patel -
 
  G701 GPCRs in Drug Discovery   A Wide Range of Compound Efficacies Revealed Using Pathhunter™ Arrestin Assays
DiscoveRx Corporation -
 
  G705 GPCRs in Drug Discovery   Automated 1,536-Well Camp Assay for the Characterization of Agonists and Antagonists of A Gi-Coupled Receptor Using the New LANCE Ultra CAMP Kit
Lucille Beaudet -
 
  G727 GPCRs in Drug Discovery   Automation of a Microplate Cell-based Assay to Measure Activity of the Histamine H1 G-protein-coupled receptor using GEM, a 3-D Cell Culture Matrix
Nadia Badr -
 
  G715 GPCRs in Drug Discovery   Capturing Higher-Value GPCR Screening Data with a Combined Approach: The FLIPRTETRA® System and the Cellkey® System
Debra Gallant -
 
  G724 GPCRs in Drug Discovery   Comparison Between The Path Hunter® Assay And The Flipr Tetra® System Cell-Based Assays For The Identification Of Human Oxytocin Receptor Agonists
William Janzen -
 
  G720 GPCRs in Drug Discovery   Development of a Generic Sensor of GPCR Activation Using a Phospho-ERK2 Cellular Assay
Bonnie Hanson -
 
  G730 GPCRs in Drug Discovery   Division Arrested Cells Expressing G-Protein Coupled Receptors
Helena Mancebo -
 
  G710 GPCRs in Drug Discovery   Exploration of G-Protein Coupled Receptor Activity with Cellul'Erk: The Htrf Solution for Measuring Activated ERK1/2 Directly in Cell
Arturo Gonzalez -
 
  G707 GPCRs in Drug Discovery   Expression, Capture and Display of Native GPCRS on Soluble Mammalian Membrane Particles
Sanjay Vasu -
 
  G708 GPCRs in Drug Discovery   Fragment-Based GPCR Screening: Histamine Receptor Sub-Type Specific Leads Identified
Thomas Hesterkamp -
 
  G709 GPCRs in Drug Discovery   Functional Profiling of Allosteric Modulators for Metabotropic Glutamate Receptors
Michel Detheux -
 
  G731 GPCRs in Drug Discovery   Functional Screening of Allosteric Modulators for G-Protein Coupled Receptors
Helena Mancebo -
 
  G725 GPCRs in Drug Discovery   Give Your GPCR a Second Chance
Stephan Schann -
 
  G728 GPCRs in Drug Discovery   GPCR Ligand Bias: Comparing results from Ca Flux, Beta Arrestin, and Impedance Measurements for CCR2b Antagonists
Sujatha Gopalakrishnan -
 
  G702 GPCRs in Drug Discovery   HitHunter ™cAMP and cAMP Hunter™HitHunter ™cAMP and cAMP Hunter™ Cell Lines: Your Solution for Use with High Serum Samples, Difficult Gi Targets and Identification of Allosteric Modulators Cell Lines: Your Solution for Use with High Serum Samples, Difficult Gi Targets and Identification of Allosteric Modulators
DiscoveRx Corporation -
 
  G711 GPCRs in Drug Discovery   Identification of Novel Selective CB2 Agonists for Pain Treatment through an HTA Campaign with ChAMPion Technology
Daniele Carettoni -
 
  G712 GPCRs in Drug Discovery   Identifying Positive Allosteric Modulators of a G-Protein Coupled Receptor Using A 2.0 uL Functional Cell Based Assay
Jeffrey Heath -
 
  G713 GPCRs in Drug Discovery   Imaging System Enhancements to Enable Insightful High Content Analysis Investigations.
Hayley A. Tinkler -
 
  G714 GPCRs in Drug Discovery   Label-Free Signaling Analysis of Fresh and Frozen Recombinant GPCR Cells Using The Corning EPIC® System
Janet Park -
 
  G706 GPCRs in Drug Discovery   Lance Ultra Camp: A New, Two-Component Tr-Fret Camp Assay for HTS Of Gs- and Gi-Coupled Receptors
Lucille Beaudet -
 
  G716 GPCRs in Drug Discovery   MC4R: Another Shot on Goal via Positive Allosteric Modulation
Lawrence Wolfe -
 
  G717 GPCRs in Drug Discovery   Natural Ligand Identification of Orphan Receptors Using Tissue Extract Screening
Michel Detheux -
 
  G703 GPCRs in Drug Discovery   PathHunter™ ß-Arrestin Assays: Determination of Pharmacology Differences between Human and Ortholog GPCRs
DiscoveRx Corporation -
 
  G721 GPCRs in Drug Discovery   Profiling 37 Orphan GPCR Cell Lines In an Effort to Identify Tool Compounds
David Bell -
 
  G722 GPCRs in Drug Discovery   Quencher Dyes can Alter The Pharmacokinetic Response Profiles of Living Cells in Fluorescence-Based Calcium Mobilization Assays
Wayne Patton -
 
  G723 GPCRs in Drug Discovery   Real-Time and High Throughput Measurement of cAMP in Live Cells Using Quest Fluo-8 Calcium Indicator
Jack Diwu -
 
  G704 GPCRs in Drug Discovery   Unique Properties of PathHunter™ ß-Arrestin Assays for GPCR Antagonist Discovery and Characterizationn
DiscoveRx Corporation -
 
  G718 GPCRs in Drug Discovery   Top Ten Winning Poster
Use of Multiplexing in the Evaluation of Prokineticin Receptor Ligands
Lisa Saville -
 
  G726 GPCRs in Drug Discovery   Validation of ßarrestin Technology for the Identification of Inverse Agonists at the Cannabinoid 1 Receptor
Lucy M. Rogers -
 
  H800 Ion Channels and Transporters in Drug Discovery   A Fast and Simple Method For Measuring P-Glycoprotein (Ppg) Inhibition - The Fluorosome®-Trans-Pgp Assay and the Fluostar Omega
EJ Dell -
 
  H801 Ion Channels and Transporters in Drug Discovery   AMRI Natural Product Libraries as a Source of Lead Compounds for the Treatment of Cystic Fibrosis
Jeffrey Webster -
 
  H802 Ion Channels and Transporters in Drug Discovery   Characterization Of TRPV1 Channel Over-Expressed In Breast Cancer Cell Line Using Flipr Calcium And MTS Cell Viability Assays
Tina Wu -
 
  H803 Ion Channels and Transporters in Drug Discovery   Generation of a High Throughput GABAA Receptor Assay to Detect Benzodiazepines
Cathryn Adams -
 
  H804 Ion Channels and Transporters in Drug Discovery   High-Throughput Luminescence-Based Assay For Identifying CRAC Channel Inhibitors As Novel Therapeutic Agents For Immune Disease Treatment
Sabrina Corazza -
 
  H812 Ion Channels and Transporters in Drug Discovery   Identification of TRPC6 Blockers as Potential Therapeutics
Mariet Lee Varban -
 
  H807 Ion Channels and Transporters in Drug Discovery   Label-Free Ion Channel Assays Using The Corning® EPIC® System
Randle David -
 
  H811 Ion Channels and Transporters in Drug Discovery   Optimizing A Transient Receptor Potential (TRP) Channel Assay On The Fliprtetra® Instrument Using hTRPV1-HEK293 Cells And The FLIPR® Calcium 5 Assay Kit
Carole Crittenden -
 
  H808 Ion Channels and Transporters in Drug Discovery   Parallel Pharmacological Characterization Of Multiple Ion Channels Involved In Cardiac Risk Assessment Using Qpatch HTX.
Hervør Lykke Olsen -
 
  H809 Ion Channels and Transporters in Drug Discovery   Screening of Drug Candidates against Malaria using a Novel Surface Plasmon Resonance (SPR) based Method
Magnus Brändén -
 
  H810 Ion Channels and Transporters in Drug Discovery   Sodium Channel Screening for Drug Discovery
Stephen Smith -
 
  I900 Kinases and Other Enzymes in Drug Discovery   A Continuous, Competitive Binding Assay To Determine Kinetic Rate Constants For Enzyme Inhibitors
Rachel Totoritis -
 
  I901 Kinases and Other Enzymes in Drug Discovery   A Flexible Kinase Inhibitor Assay for Active, Non-Activated, and Impure Kinase Preparations
Randy Hoffman -
 
  I902 Kinases and Other Enzymes in Drug Discovery   A Homogeneous Fluorimetric HDAC Activity Assay Using Non-Peptide HDAC Green Substrate
Jack Diwu -
 
  I903 Kinases and Other Enzymes in Drug Discovery   Activity-Based Kinase Selectivity Profiling of Clinically Relevant Tyrosine Kinase Inhibitors Using Quickscout™
Masaki Gouda, Ph. D. -
 
  I904 Kinases and Other Enzymes in Drug Discovery   ADP Detection in FP, TR-FRET and FI Assay Formats: Versatile Kinase/ATPase Detection without the Use of Coupling Enzymes
Karen Kleman-Leyer, PhD -
 
  I905 Kinases and Other Enzymes in Drug Discovery   ADP Quest™ and ADP Quest™ HS: Universal ADP Accumulation Assay for Enzyme Kinetics
DiscoveRx Corporation -
 
  I923 Kinases and Other Enzymes in Drug Discovery   Top Ten Winning Poster
Biochemical Characterization of a Small Molecule Glycogen Synthase Activator
Qing Xiang -
 
  I907 Kinases and Other Enzymes in Drug Discovery   Comparison Of Binding And Activity Kinase Assays To Identify And Validate Fragment Hits For FBDD
Gary Asmussen -
 
  I908 Kinases and Other Enzymes in Drug Discovery   Competitive TR-FRET Binding Assays for PI3K Family Inhibitors
William J. Frazee -
 
  I909 Kinases and Other Enzymes in Drug Discovery   Convenient Kit for Assay of DPPIV/CD26 Activity in Biological Fluids
Diana L. Hulboy, PhD -
 
  I910 Kinases and Other Enzymes in Drug Discovery   Determination of Drug-Kinase Residence Time in a Homogenous, Low-Volume Format
Pete Conway -
 
  I911 Kinases and Other Enzymes in Drug Discovery   Development Of A High-Throughput Screen For Natural Product Inhibitors Of Human Tyrosyl-DNA-Phosphodiesterase (Tdp1)
Alun Bermingham -
 
  I912 Kinases and Other Enzymes in Drug Discovery   Drug Discovery Applications of the LanthaScreen® Eu Kinase Binding Assay Technology for Assay Development, HTS & Hit Validation of Novel Kinases
Michael Kuranda -
 
  I913 Kinases and Other Enzymes in Drug Discovery   Evaluation of Lanthascreen™ Eu Kinase Binding Assay And Comparison to Three Mechanistically Distinct Kinase Assays for ITK
Mohammed Kashem -
 
  I914 Kinases and Other Enzymes in Drug Discovery   From Target ID to High Throughput Screening: The Development of a Kinase Assay to Screen in 3456-well Plates
Daniel Riley -
 
  I915 Kinases and Other Enzymes in Drug Discovery   Homogeneous, Luminescence-Based Assay for Selectivity Profiling of the Kinome
Reena Zutshi -
 
  I916 Kinases and Other Enzymes in Drug Discovery   HotSpot(SM): A Novel Methyltransferase Assay Platform for Drug Screening and Discovery
Haiching Ma -
 
  I917 Kinases and Other Enzymes in Drug Discovery   Identification of Natural Product Inhibitors of Human Tyrosyl-DNA-Phosphodiesterase (Tdp1)
Edmund Price -
 
  I918 Kinases and Other Enzymes in Drug Discovery   Identification of Potent and Selective Cdc2-Like (Clk) Kinase Inhibitors Via an Orthogonal Assay Approach
Cordelle Tanega -
 
  I919 Kinases and Other Enzymes in Drug Discovery   Kinase Inhibitor Selectivity Profiling Utilizing a Versatile Tr-Fret Kinase Binding Assay Platform
Elizabeth J. Miller -
 
  I920 Kinases and Other Enzymes in Drug Discovery   Optimizing the Cost-Effectiveness of Large-Scale Kinase Profiling
Dongyu Sun -
 
  I921 Kinases and Other Enzymes in Drug Discovery   P38Alpha: A Fragment-Based Drug Discovery Case Study At Biofocus
David Cronk -
 
  I922 Kinases and Other Enzymes in Drug Discovery   Parameters for Fluorescence Lifetime Kinase Assays
Pierre Graves -
 
  I906 Kinases and Other Enzymes in Drug Discovery   PathHunter™ Cell-Based Kinase Assays: A Portfolio of HTS-friendly Cytoplasmic or Receptor Tyrosine Kinase Assays for Small Molecule Inhibitors as well as Monoclonal Antibodies
DiscoveRx Corporation -
 
  I927 Kinases and Other Enzymes in Drug Discovery   Phosphatase Assays Using the LANCE Ultra Technology
Lucille Beaudet -
 
  I924 Kinases and Other Enzymes in Drug Discovery   Profiling Kinase Activities Using A Universal Luminescent ADP Detection Platform
Hicham Zegzouti -
 
  I929 Kinases and Other Enzymes in Drug Discovery   Simultaneous Monitoring of Phosphorylation Events and Protein-Protein Interactions in the ERK MAP Kinase Pathway
Mathieu Arcand -
 
  I928 Kinases and Other Enzymes in Drug Discovery   Target Immobilization as a Strategy for NMR Based Fragment Screening: Comparison of TINS, 1D-STD and SPR for Fragment Hit Identification
Robert J. Heetebrij -
 
  I925 Kinases and Other Enzymes in Drug Discovery   The Transcreener® ADP2 Universal Kinase Assay from BellBrook Labs is Readily Performed on Two BMG LABTECH Microplate Readers Using Different Assay Formats
EJ Dell -
 
  I926 Kinases and Other Enzymes in Drug Discovery   Ultrasensitive Western Blot and AlphaScreen SureFire Assays - Complementary Tools for Studying Cellular Kinase Signaling Pathways
Stephen Hurt -
 
  J1000 Lead Discovery in Immunoinflammation   Top Ten Winning Poster
A Microconduit Array Plate Designed for High Content Leukocyte Chemotaxis Assays in the Presence of a Stable Gradient
Tracy Worzella -
 
  J1001 Lead Discovery in Immunoinflammation   Achieving Appropriate Species Cross Reactivity with Antibody Therapeutics.
Wendy Williams -
 
  J1009 Lead Discovery in Immunoinflammation   Flavocoxid, a Natural, Novel Flavonoid-Based Anti-inflammatory with a Broad Mechanism of Action Providing Safer and Effective Inflammatory Management of Disease
Bruce Burnett -
 
  J1003 Lead Discovery in Immunoinflammation   High-Throughput Multiplexed Inflammation Assay Using Primary Cells
Evan F. Cromwell -
 
  J1004 Lead Discovery in Immunoinflammation   Identification and Characterisation of Novel Dual TBK1/IKKe Inhibitors
Ahmad Kamal -
 
  J1005 Lead Discovery in Immunoinflammation   Inhibitors of Cyclin Dependent Kinase 9
Jan Eickhoff -
 
  J1006 Lead Discovery in Immunoinflammation   Kinobeads(TM) as an Enabling Technology for the Discovery of Novel
Dan Leggate -
 
  K1104 Lead Discovery in Neurosciences   A High Throughput Kinetics Imaging Detector for Measuring Intracellular Calcium Increase Through Cold Activation Of Ion Channels
Judy Wang -
 
  K1105 Lead Discovery in Neurosciences   A Ligand Gated Ion Channel Assay on the IonFlux Automated Electrophysiology Platform
Cristian Ionescu-Zanetti -
 
  K1100 Lead Discovery in Neurosciences   Application of Process Mapping for Establishing a High-Capacity Neuronal Cell Culture Facility at Bristol-Myers Squibb
Sandra Armento -
 
  K1101 Lead Discovery in Neurosciences   Demonstration of constitute activity of the class B orphan GPCR (LPHN1), using beta- Lactamase reporter system.
Victoria Yatsula -
 
  K1108 Lead Discovery in Neurosciences   High-Throughput Screening in Embryonic Stem Cell-derived Neurons to Identify Potentiators of AMPA-type Glutamate Receptors
Laura Zawadzke -
 
  K1102 Lead Discovery in Neurosciences   Identification of Potent and Selective Inhibitors of LRRK2
Alison Levy -
 
  K1106 Lead Discovery in Neurosciences   Multidimensional Investigation Of Cell Surface Receptors Using The Tag-Lite™ Technology
Thomas Roux -
 
  K1107 Lead Discovery in Neurosciences   Novel Platform for Highly Parallel Patch Clamp Recordings - A Revolution In Ion Channel Screening
Rodolfo J. Haedo -
 
  K1103 Lead Discovery in Neurosciences   Strategy for the Identification and Development of Novel JNK3 Inhibitors as Therapeutics for Huntingtons Disease
Macarena Irigoyen -
 
  L1208 Lead Discovery in Oncology Research   A Novel Automatable Cell Migration Assay for High Content Screening
Scott Gehler -
 
  L1200 Lead Discovery in Oncology Research   An Automated High-Content Assay for Tumor Cell Migration Through 3-Dimensional Matrices
Steven Hayes -
 
  L1209 Lead Discovery in Oncology Research   Cell-impedance Sensing Cell Survival Assay for Assessment of Nanoparticles Enhanced Radio-sensitivity in Cancer
James Xing -
 
  L1201 Lead Discovery in Oncology Research   Characterization Oof an Allosteric Inhibitor Targeting The MAPK Cascade: From Phenotypic Effects to Molecular Interactions
Laurent Pépin -
 
  L1202 Lead Discovery in Oncology Research   Top Ten Winning Poster
Development of a 10-Parameter High Content Screening Assay Panel for Elucidation of Mechanism of Action of Cytotoxic Compounds for Drug Discovery
Vivek Abraham -
 
  L1210 Lead Discovery in Oncology Research   Development of Tools for 3D High Content Screening
Jeff Price -
 
  L1203 Lead Discovery in Oncology Research   Evaluation of Nuclear Hormone Receptor Cell Assay Approaches - Comparison of the Discoverx Pathhuntertm Format Versus Reporter nd Endogenous End-Points.
Graeme E. Walker -
 
  L1204 Lead Discovery in Oncology Research   High Content Analysis (HCA) Approaches in Development of Differentially Conditioned Human Melanoma Cell Lines as Tools for Screening and Characterization of Therapeutic Drug Candidates
Elizabeth Roquemore, PhD -
 
  L1205 Lead Discovery in Oncology Research   High-Content Screen for Inhibitors of Cell Migration in Cancer Metastasis Using Adenoviral Knock-Down
Nathalie Joly -
 
  L1211 Lead Discovery in Oncology Research   Impedance Based Kinetic Monitoring of Cellular Response In Drug Discovery and Development
Ning Ke -
 
  L1215 Lead Discovery in Oncology Research   Top Ten Winning Poster
Mode of Action Analysis of Sorafenib by Integrating Chemical Proteomics and Phosphoproteomics
Jutta Fritz -
 
  L1206 Lead Discovery in Oncology Research   Natural Products Targeting Oncology Pathways
Peter Eckard -
 
  L1212 Lead Discovery in Oncology Research   Poly(ADP Ribose)Polymerases: Profiling of Inhibitor Selectivity dor Parp-Family Members Using Biacore™ Technology
Johan Weigelt -
 
  L1213 Lead Discovery in Oncology Research   Residence Time and Thermodynamics: How Novel High Throughput Binding Assays Impact Drug Discovery
Lars Neumann -
 
  L1207 Lead Discovery in Oncology Research   Utilizing Primary Cell-Based Screening with the Exvitech© Platform to Identify Novel Uses for Existing Drugs
Teresa Bennett -
 
  M1309 Other Targets in Drug Discovery   A High Throughput Screen For Phop Regulon Inhibitors in Salmonella Typhi
LaKeisha Woods -
 
  M1310 Other Targets in Drug Discovery   A High Throughput Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis To Beta-Lactam Antibiotics
Clinton Maddox -
 
  M1300 Other Targets in Drug Discovery   A Novel Fluorimetric Assay for the Detection of Separase Enzyme Activity
Xiaohe Tong -
 
  M1311 Other Targets in Drug Discovery   Activity-Based Profiling of the Atpome of Dormant Mycobacterium Tuberculosis
Krister Wennerberg -
 
  M1312 Other Targets in Drug Discovery   CCR5-Tropic HIV-1 Fusion Inhibition Assay for HTS
Kanupriya Whig -
 
  M1301 Other Targets in Drug Discovery   Detection of Cell Response to Pharmacologically Active Compounds Across Many Signaling Pathways in a Single Label-free Platform
Todd Upton -
 
  M1313 Other Targets in Drug Discovery   Development of a High Throughput Screening Strategy for the Oncogenic And Cytokinetic RhoGEF Ect2
Corey Thomas -
 
  M1314 Other Targets in Drug Discovery   Dynamic Multi-Mode Spectroscopy (DMS) As a Tool for Assessing the Stability of a Protein Molecule.
Chris Smith -
 
  M1315 Other Targets in Drug Discovery   Functional, Cell-Based Pathway Assays Using Pathhunter™Technology
DiscoveRx Corporation -
 
  M1316 Other Targets in Drug Discovery   Genome Wide Screen to Identify Proteins Involved In Regulation of Soluble Levels of Disease Causing Mutant of Superoxide Dismutase 1
Balajee Somalinga -
 
  M1304 Other Targets in Drug Discovery   High Throughput DNA Analysis and Quantization Using Microliter Scale Sample Volumes
Hanna Grano -
 
  M1317 Other Targets in Drug Discovery   High Throughput Screen Assays for Identifying Inhibitors of Protein-RNA Binding as a Potential Treatment for Myotonic Dystrophy Type-1
Catherine Chen -
 
  M1305 Other Targets in Drug Discovery   Interaction of Ibogaine with Human A3ß4 Nicotinic Acetylcholine
Matthew Crunden -
 
  M1306 Other Targets in Drug Discovery   Kinaffinityâ Facilitates Effective and Reliable Profiling of Kinase Inhibitors In Cells and Tissue
Jutta Fritz -
 
  M1307 Other Targets in Drug Discovery   Meganucleases with Tailored Specificities for Genome Engineering Purposes
Jean-Charles Epinat -
 
  M1308 Other Targets in Drug Discovery   NIH Roadmap Molecular Libraries Probe Production Centers Network (MLPCN) --- A Resource for the Research Community
Ingrid Li -
 
  M1319 Other Targets in Drug Discovery   Novel Screening Assay and Development of Potent Inhibitors of H-PGDS
Jeff Johnson, PhD -
 
  M1320 Other Targets in Drug Discovery   Targeting RGS Proteins using Engineered Galpha Proteins and the Transcreener GDP Assay
Robert Lowery -
 
  M1321 Other Targets in Drug Discovery   The Influence of Data Content in Deriving Polypharmacology Relationships
Emily Nicholl -
 
  001 Other Targets in Drug Discovery   Utilizing a Standard Language in an EHR to Collect Data for Quality Programs, Research, and Reporting
Carol A. Petersen, RN, BSN, MAOM, CNOR -
 

 

 
www.MeetingPosters.com © 2012  CadmiumCD, LLC. All Rights Reserved. Unauthorized Duplication Prohibited.